mTORC1 inhibitors rapamycin and everolimus as host-directed therapy for tuberculosis
Infect Immun
.
2026 Feb 10;94(2):e0054425.
doi: 10.1128/iai.00544-25.
Epub 2026 Jan 21.
Authors
Robin H G A van den Biggelaar
1
,
Tom H M Ottenhoff
1
Affiliation
1
Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
PMID:
41563248
PMCID:
PMC12890025
DOI:
10.1128/iai.00544-25
No abstract available
Keywords:
Mycobacterium tuberculosis; everolimus; host-directed therapy; mTOR inhibitors; rapamycin.
Publication types
Letter